Theravance Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TBPH and other ETFs, options, and stocks.About TBPH
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments.
TBPH Key Statistics
Stock Snapshot
The current Theravance Biopharma(TBPH) stock price is $13.66, with a market capitalization of 692.18M. The stock trades at a price-to-earnings (P/E) ratio of 24.29.
On 2026-03-05, Theravance Biopharma(TBPH) stock moved within a range of $13.40 to $13.90. With shares now at $13.66, the stock is trading +1.9% above its intraday low and -1.7% below the session's peak.
Trading activity shows a volume of 618.81K, compared to an average daily volume of 1.08M.
Over the past 52 weeks, Theravance Biopharma(TBPH) stock has traded between a high of $21.03 and a low of $7.90.
Over the past 52 weeks, Theravance Biopharma(TBPH) stock has traded between a high of $21.03 and a low of $7.90.
TBPH News
Oppenheimer analyst Trevor Allred downgraded Theravance Biopharma (TBPH) to Perform from Outperform. Published first on TheFly – the ultimate source for real-t...
B. Riley downgraded Theravance Biopharma (TBPH) to Neutral from Buy with a price target of $14, down from $28. The company reported that the Phase 3 CYPRESS stu...
Theravance Biopharma ( (TBPH) ) has provided an announcement. On March 3, 2026, Theravance Biopharma reported that its Phase 3 CYPRESS trial of ampreloxetine i...
Analyst ratings
57%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.